Dietary omega-3 fatty acids (FAs) were first linked to primary prevention of colorectal cancer (CRC) in large epidemiological studies, after which observational data in humans linked omega-3 FA status to the prognosis of CRC.
Worldwide, breast cancer is one of the most common forms of cancer in women and in the last decade there has been an increase in newly diagnosed cases. In 2015, approximately 1.6 million new cases of breast cancer were diagnosed in women around the world.
Surgical resection is the principal treatment in early stages of gastro-intestinal (GI) cancer, but involves the risk of developing several complications, including malnutrition, tumour-induced immunosuppression, surgical stress and inflammation.
Worldwide, colorectal cancer (CRC) is the third most frequent cancer in men, the second most common in women and the fourth leading cause of cancer-related death.
A study by Zhang G. et al.
William Aronson and his team, researchers at the University of California Los Angeles (UCLA), have undertaken a thorough study of the relationship between prostate cancer and fatty acids.
Research into the use of the omega-3 polyunsaturated fatty acids eicosapentaenoic acid (EPA) anddocosahexaenoic acid (DHA) in the prevention and treatment of cancer shows that omega-3 may exert anti-carcinogenic actions by influencing the proces
The role of nutrition in preventing cancer is sufficiently well established. Dietary agents have been shown to suppress transformative, hyperproliferative and inflammatory processes that initiate carcinogenesis.